Home Infusion Therapy Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
The global home infusion therapy market is projected to witness tremendous expansion over the coming years due to the increasing instances of chronic diseases. Additionally, an upsurge in the global geriatric population would further complement the market growth. Home infusion is generally used to manage complicated conditions like immune globulin therapy. Infusion therapy is generally employed as an oral treatment alternative and involves dosage of respective medications using a sterile catheter, generally inserted into the patient’s vein. Home infusion therapy can be given to a patient in outpatient infusion therapy centers or even inside their home by trained nurses.
Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/435
Additionally, the growing stress the COVID-19 pandemic is exerting on hospitals is further expected to augment the home infusion therapy market share. Citing an instance, in April 2020, Option Care Health, a renowned home and alternate infusion service provider, collaborated with health systems throughout the U.S. to move COVID-19 patients out of hospitals as early as possible. The firm is helping hospitals by helping them discharge low-risk patient quicker and move their treatment to home-based infusion therapy. This initiative would allow hospitals to divert their resources to patients that are suffering from highly-acute coronavirus infections.
In terms of product, the market is categorized into the infusion pump, intravenous sets, IV cannulas, and needleless connectors. Among these, the needleless connectors segment accounted for a valuation of about $6.2 billion back in 2019 and is likely to foresee considerable growth over the coming years. These products offer better safety, enable smooth surgeries, and help the medical care providers to adhere to greater clinical practices. All these aforementioned factors would play a crucial role in augmenting the segment expansion.
With regards to application, the market is bifurcated into anti-infective, chemotherapy, hydration therapy, parenteral nutrition, enteral nutrition, and specialty pharmaceuticals. Of these, the parenteral nutrition segment is estimated to expand at approximately 12% through the forecast timeframe. The growing geriatric population, high natality rate, and significant presence of malnourished pediatric population across the world are majorly driving the segment size. The aforementioned demographics face issues when it comes to consuming adequate amount of nutrition through the oral route, warranting the need for parenteral nutrition.
In 2019, the Latin America home infusion therapy industry accounted for a tremendous market valuation of $948 million. The segment is further likely to experience a remunerative growth trend over the coming years. This projected growth is ascribed to the increasing geriatric population in the region that requires home infusion therapy. In fact, according to the NCBI (National Center for Biotechnology Information), an estimated 71 million people fall under the age of 60 or more in Latin America and the Caribbean. This count represents about 11.2 percent of the total population of the region.
With rising end-user population and favorable revenue growth conditions, key industry players to are focusing on strategies that can rapidly increase their customer pools and revenues. Taking December 2019 for instance, OptumRx, pharmacy care services division of United Health, and Diplomat, a specialty pharmacy and infusion services provider reportedly signed an agreement to merge their businesses. As part of the deal, OptumRx would acquire Diplomat’s outstanding common stock for $4 per share using a cash tender offer as well as assumption of the company’s outstanding debt. The main objective of this acquisition was to bring Diplomat’s expertise in treating chronic diseases using therapeutic measures like immunology and oncology across onboard OptumRx.
The competitive landscape of the global home infusion therapy industry is inclusive of market players such as Cosmed, JMS Co. Ltd., Eli Lilly and Company, Terumo Corporation, ICU Medical, Smiths Medical, Becton Dickinson, Fresenius Kabi, Baxter International, and B Braun Melsungen AG among others.
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/home-infusion-therapy-market-report
Partial Chapter of the Table of Content
Chapter 4. Global Home Infusion Therapy Market, By Product
4.1. Key segment trends
4.2. Infusion Pump
4.2.1. Market size, by region, 2015-2026 (USD Million)
4.3. Intravenous sets
4.3.1. Market size, by region, 2015-2026 (USD Million)
4.4. IV cannulas
4.4.1. Market size, by region, 2015-2026 (USD Million)
4.5. Needleless connectors
4.5.1. Market size, by region, 2015-2026 (USD Million
Chapter 5. Global Home Infusion Therapy Market, By Application
5.1. Key segment trends
5.2.1. Market size, by region, 2015-2026 (USD Million)
5.3. Hydration therapy
5.3.1. Market size, by region, 2015-2026 (USD Million)
5.4.1. Market size, by region, 2015-2026 (USD Million)
5.5. Enteral Nutrition
5.5.1. Market size, by region, 2015-2026 (USD Million
5.6. Parenteral Nutrition
5.6.1. Market size, by region, 2015-2026 (USD Million
5.7.1. Market size, by region, 2015-2026 (USD Million)